Androgen receptor protein in the androgen-dependent Dunning R-3327 prostate carcinoma.

The rat prostate carcinoma (Dunning R-3327) contains a relatively high concentration of androgen receptor (80 to 150 fmol/mg cytosol protein). We characterized this receptor for comparison with androgen receptors in normal organs of the rat. Binding of testosterone and dihydrotestosterone was of high affinity (Ka = 2 X 10(9) M). Rates of dissociation were slow (t 1/2 testosterone = 60 hr; t 1/2 dihydrotestosterone = approximately 160 hr). At low ionic strength, the receptor was in an 8S form which dissociated to 4.5 to 5.0S in the presence of 0.4 M KCl. Fractionation of [3H]dihydrotestosterone cytosol by chromatography on phosphocellulose yielded a single peak of radioactivity eluting at 0.2 M Cl-. Determination of size at high ionic strength by gel filtration chromatography and sucrose gradient centrifugation indicated a Stokes radius of 53 A and sedimentation coefficient of 5S (M.W. 115,000). Cytosols occasionally yielded a second peak of radioactivity eluting from phosphocellulose at 0.29 M Cl-. This fraction contained a smaller receptor [36 A, 3.6S (M.W. 55,000)]. Both receptor forms were observed in cytosols from the normal dorsal prostate. The larger high-salt form of the receptor is identical to native androgen receptor in normal tissues. Smaller receptor forms in the tumor and in normal androgen-responsive tissues have been shown previously to result from proteolytic cleavage of the native receptor during extraction.

[1]  F. S. French,et al.  Characterization of different forms of the androgen receptor. , 1979, Endocrinology.

[2]  F. S. French,et al.  Effects of proteases and protease inhibitors on the 4.5 S and 8 S androgen receptor. , 1979, The Journal of biological chemistry.

[3]  P. Walsh,et al.  Androgen, estrogen and progesterone receptors of the R3327H Copenhagen rat prostatic tumor. , 1979, Cancer letters.

[4]  L. Lee,et al.  Characterization and comparison of the estrogen and androgen receptors from the R-3327 rat prostatic adenocarcinoma. , 1979, Journal of steroid biochemistry.

[5]  D. S. Coffey,et al.  Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT. , 1978, Cancer research.

[6]  F. Markland,et al.  Characterization of steroid hormone receptors in the Dunning R-3327 rat prostatic adenocarcinoma. , 1978, Cancer research.

[7]  F. S. French,et al.  Androgen-Binding Proteins of the Male Rat Reproductive Tract , 1978 .

[8]  D. S. Coffey,et al.  Experimental models for the study of prostatic adenocarcinoma. , 1977, The Journal of urology.

[9]  D. S. Coffey,et al.  Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer. , 1977, Cancer treatment reports.

[10]  D. S. Coffey,et al.  Cell kinetic studies of prostatic cancer: adjuvant therapy in animal models. , 1977, Oncology.

[11]  F. S. French,et al.  Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. , 1976, The Journal of biological chemistry.

[12]  M. Feldman,et al.  5α-Dihydrotestosterone-binding Proteins and Androgen Sensitivity in Prostatic Cancers of Copenhagen Rats , 1975 .

[13]  W. Voigt,et al.  In vivo metabolism of testosterone-3H in R-3327, an androgen-sensitive rat prostatic adenocarcinoma. , 1974, Cancer research.

[14]  W. F. Dunning PROSTATE CANCER IN THE RAT. , 1963, National Cancer Institute monograph.

[15]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.